We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Legislation title: Guidance on the application of Plant Protection Products (PPPs) for phytosanitary treatment of oak processionary moth (OPM).
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
DHSC publications relating to COVID-19 treatments and clinical trials.
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Current issues relating to imports and exports of animals and animal products.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
Actions that trial sponsors should consider to build resilience into clinical trial design
The way you apply to licence biological products has changed
Information on cleaning an oil spill including your options, how to get a product approved and how long it will take.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Collection of documents relating to COVID-19 treatments.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).